• NEWS

The world’s first CRISPR therapy is approved: who will receive it?

Misshapen red blood cells clump and clog blood vessels in sickle cell disease, depriving tissues of oxygen and causing severe pain. Credit: H.S. Photos / Alamy Stock Photo

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature Biotechnology 42, 3-4 (2024)

doi: https://doi.org/10.1038/d41587-023-00016-6

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing